AI Article Synopsis
- ID/HIV physicians play a crucial role in advocating for effective treatment and policies that enhance healthcare for both adults and children suffering from infectious diseases.
- These professionals use their firsthand experiences to inform federal policymakers about the importance of programs that support public health and patient care.
- The article highlights key advocacy issues, including funding for ID/HIV programs, enhancing public health access, promoting research opportunities, and supporting future clinicians in the field.
Article Abstract
ID/HIV physicians and other healthcare professionals advocate within the healthcare system to ensure adults and children receive effective treatment. These advocacy skills can be used to inform domestic and global infectious disease policies to improve healthcare systems and public health. ID/HIV physicians have a unique frontline perspective to share with federal policymakers regarding how programs and policies benefit patients and public health. Providing this input is critical to the enactment of legislation that will maximize the response to infectious diseases. This article discusses the advocacy of ID/HIV physicians and other healthcare professionals in federal health policy. Key issues include funding for ID/HIV programs; the protection of public health and access to health care; improving research opportunities; and advancing the field of ID/HIV, including supporting the next generation of ID/HIV clinicians. The article also describes best practices for advocacy and provides case studies illustrating the impact of ID/HIV physician advocacy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087129 | PMC |
| http://dx.doi.org/10.1093/jpids/piaa128 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ID/HIV Physician Ambassadors: Advancing Policy to Improve Health.
J Pediatric Infect Dis Soc
April 2021
Infectious Diseases Physicians, Inc., Annandale, Virginia, USA.
Article Synopsis
- ID/HIV physicians play a crucial role in advocating for effective treatment and policies that enhance healthcare for both adults and children suffering from infectious diseases.
- These professionals use their firsthand experiences to inform federal policymakers about the importance of programs that support public health and patient care.
- The article highlights key advocacy issues, including funding for ID/HIV programs, enhancing public health access, promoting research opportunities, and supporting future clinicians in the field.
Infectious Diseases/Human Immunodeficiency Virus Physician Ambassadors: Advancing Policy to Improve Health.
Clin Infect Dis
October 2021
Infectious Diseases Physicians, Inc, Annandale, Virginia, USA.
Article Synopsis
- ID/HIV physicians and healthcare professionals advocate for effective treatment to enhance healthcare systems and public health both domestically and globally.
- They provide crucial insights to federal policymakers about the real-life impacts of health programs and policies on patients.
- The article explores key advocacy issues such as funding, access to healthcare, research opportunities, and supports for future ID/HIV clinicians, while also sharing best practices and case studies highlighting successful advocacy efforts.
Survey of physician knowledge regarding antiretroviral medications in hospitalized HIV-infected patients.
J Int AIDS Soc
February 2009
Infectious Disease Division, Baystate Medical Center-Tufts University School of Medicine, Springfield, Massachusetts, USA.
Background: Antiretroviral prescribing errors are common among hospitalized patients. Inadequate medical knowledge is likely one of the factors leading to these errors. Our objective was to determine the proportion of hospital physicians with knowledge gaps about prescribing antiretroviral medications for hospitalized HIV-infected patients and to correlate knowledge with length and type of medical training and experience.
View Article and Find Full Text PDFSerum LDH level as a clue to the diagnosis of histoplasmosis.
AIDS Read
July 2002
University of Pittsburgh, ID-HIV Clinics, Pittsburgh VA Healthcare System, Pittsburgh, USA.
The purpose of this study was to determine whether serum lactate dehydrogenase (LDH) level could be used as an adjunct clinical marker to differentiate between histoplasmosis and Pneumocystis carinii pneumonia (PCP). In a retrospective, case-controlled study, 30 patients with a diagnosis of histoplasmosis (all but 1 with disseminated disease) were compared with 120 patients with PCP (33 patients with definitive PCP, 87 with presumed PCP). Groups were matched for CD4+ lymphocyte counts, sex, and year of diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!